EDGEWISE THERAPEUTICS INC's ticker is EWTX and the CUSIP is 28036F105. A total of 73 filers reported holding EDGEWISE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $20,227 | -35.9% | 3,530 | -13.3% | 0.00% | – |
| Q2 2023 | $31,543 | +30.4% | 4,070 | +12.0% | 0.00% | – |
| Q1 2023 | $24,184 | -25.5% | 3,634 | 0.0% | 0.00% | – |
| Q4 2022 | $32,452 | +29.8% | 3,634 | +41.2% | 0.00% | – |
| Q3 2022 | $25,000 | +25.0% | 2,574 | +2.3% | 0.00% | – |
| Q2 2022 | $20,000 | -54.5% | 2,516 | -45.8% | 0.00% | – |
| Q1 2022 | $44,000 | -38.0% | 4,638 | -0.3% | 0.00% | – |
| Q4 2021 | $71,000 | +129.0% | 4,651 | +149.4% | 0.00% | – |
| Q3 2021 | $31,000 | -22.5% | 1,865 | 0.0% | 0.00% | – |
| Q2 2021 | $40,000 | – | 1,865 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 1,553,661 | $8,902,478 | 11.43% |
| Novo Holdings A/S | 6,071,703 | $34,790,858 | 2.57% |
| Orbimed Advisors | 14,567,176 | $83,469,918 | 1.77% |
| Opaleye Management Inc. | 875,405 | $5,016,071 | 1.63% |
| Cormorant Asset Management, LP | 2,946,887 | $16,885,663 | 0.98% |
| DAFNA Capital Management LLC | 519,384 | $2,976,070 | 0.93% |
| EcoR1 Capital, LLC | 3,493,194 | $20,016,002 | 0.68% |
| Deep Track Capital, LP | 2,750,000 | $15,757,500 | 0.61% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,933,137 | $22,536,875 | 0.50% |
| Parkman Healthcare Partners LLC | 473,312 | $2,712,078 | 0.50% |